,Outcomes,Arm 1,Arm 2
0,intervention,vitamin E,placebo
1,primary analysis,1022 ( 21.5 % ),178 ( 3.7 % )
2,cancer incidence,1022 ( 21.5 % ),985 ( 20.6 % )
3,major cardiovascular events,552 patients ( 11.6 % ),
